Is the FDA Withholding Data about a Controversial Drug to Protect Its Manufacturer?

In the case of Sarepta, it sure looks that way

-- Read more on ScientificAmerican.com

from Scientific American News http://ift.tt/2BxuDEQ
via IFTTT

• Twitter
• Facebook
• Google
• Tumblr
• Pinterest